SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-021318
Filing Date
2021-04-28
Accepted
2021-04-28 16:00:47
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q apls-10q_20210331.htm   iXBRL 10-Q 2392675
2 EX-10.1 apls-ex101_47.htm EX-10.1 278889
3 EX-31.1 apls-ex311_8.htm EX-31.1 18438
4 EX-31.2 apls-ex312_7.htm EX-31.2 17553
5 EX-32.1 apls-ex321_9.htm EX-32.1 8560
6 EX-32.2 apls-ex322_10.htm EX-32.2 8576
  Complete submission text file 0001564590-21-021318.txt   7901567

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA apls-20210331.xsd EX-101.SCH 54113
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apls-20210331_cal.xml EX-101.CAL 43143
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apls-20210331_def.xml EX-101.DEF 165073
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE apls-20210331_lab.xml EX-101.LAB 372340
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apls-20210331_pre.xml EX-101.PRE 301269
12 EXTRACTED XBRL INSTANCE DOCUMENT apls-10q_20210331_htm.xml XML 1229057
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38276 | Film No.: 21864087
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences